There is one study suggesting diminished expression of the transmembrane glycoprotein complex dystroglycan along with altered mRNA expression of enzymes involved in dystroglycan glycosylation, including POMGnT1 and POMT2 in myeloid blasts from AML patients [66]. The gene discussed is POMT2; the disease is acute myeloid leukemia.